Capping off a highly eventful week in Asia, President Donald J. Trump has further reshaped the landscape of U.S. trade with the Asia-Pacific region through a series of new agreements. This latest round of negotiations includes new reciprocal trade deals and market access commitments across Cambodia, Thailand, Malaysia, Vietnam, China, South Korea, and Japan. Some
As Russian Energy Week concluded last week, Western governments strike to the heart of Russia’s energy sector with sanctions packages to cut of revenue that funds Russia’s continued war against Ukraine. Three significant packages were announced in October 2025: the U.S.’s sanctions targeting the Russian energy sector, the UK’s latest sanctions against the Russian oil industry,
On October 22, 2025, Reddit, Inc. filed a federal lawsuit in the Southern District of New York against Perplexity AI, Inc. and associated data-scraping firms, alleging violations of the Digital Millennium Copyright Act’s anti-circumvention provisions (17 U.S.C. §1201), along with related claims for unjust enrichment and unfair competition. Building on the strategy advanced in its
Healthcare organizations of every shape and size are rapidly expanding their use of artificial intelligence solutions from high-risk applications like clinical decision-support interventions, ambient listening, and charting to lower-risk administrative activities like automated patient communications and scheduling. While adoption is widespread and increasing in depth and breadth across the industry, not every healthcare organization has
Since the year began, we have attempted to divine the new administration’s approach to regulating human cell and tissue products (“HCT/Ps”).[1] What we have found is a collection of seemingly contradictory signals, keeping us guessing as to whether we will see an increase or decrease in HCT/P regulation – either by written regulation or
On October 2, The CFPB finalized a rule extending the compliance deadlines for its 2023 Small Business Lending Data Collection Rule under the Equal Credit Opportunity Act (ECOA) and Regulation B. The final rule confirms the Bureau’s June 2025 interim rule delaying implementation by approximately one year to align compliance timelines across institutions affected by federal
The United States Patent and Trademark Office (USPTO) is rolling out a new Automated Search Pilot Program, offering applicants a first-of-its-kind opportunity to receive a pre-examination, AI-generated prior art search report. The program’s stated goals are to improve prosecution efficiency and the quality of patent examination by providing an Automated Search Results Notice (ASRN)
The wait is over – on September 18, 2025, almost 2 years after implementing the Interim Rule, the Office of the Director of National Intelligence (“ODNI”) issued a Federal Acquisition Supply Chain Security Act (“FASCSA”) order to remove and exclude products and services from Acronis AG, a Swiss cybersecurity and data protection company. Although the
On September 9, 2025, the U.S. Food and Drug Administration (“FDA”) Office of Prescription Drug Promotion (“OPDP”) issued a torrent of untitled letters, 40 in total, just days after rumblings that FDA would be cracking down on direct to consumer (“DTC”) advertising of pharmaceuticals.[1] This enforcement flurry—which we will digest in a later blog post,
On September 8, the D.C. Attorney General filed a lawsuit in D.C. Superior Court against a crypto ATM operator alleging violations of the Consumer Protection Procedures Act and the Abuse, Neglect, and Financial Exploitation of Vulnerable Adults and the Elderly Act. The suit also alleges unlicensed money transmission activity in the District.